STK11 (serine/threonine kinase 11; LKB1) is a tumor suppressor; its loss in NSCLC disrupts AMPK signaling, rewires metabolism, and correlates with poor response to immunotherapy [70]. This evidence concerns the gene STK11 and neoplasm.